Characterization of Bacterial Pathogens of the Urinary Tract in Type 2 Diabetes Patients at Mzuzu Central Hospital, Northern Malawi ()
1. Introduction
Diabetes is a severe, chronic metabolic disease characterized by high blood glucose levels [1]. Diabetes is one of the fastest-growing global health crises of the 21st century [1] [2]. It is estimated that the number of people with diabetes in Africa will rise by 143% (47 million) by 2045 from 19.4 million among adults [2]. This is the highest predicted increase among all regions of the world [2]. About 7% (366,200) of deaths in 2019 were associated with diabetes [2]. In Malawi, the overall prevalence among adults was reported to be 5.6% by 2014 [3]. Age-sex-standardized prevalence of diabetes was 6.5%, and 4.7% in males and females respectively [3].
Infectious diseases are a major comorbidity in people living with type 2 diabetes mellitus because diabetes impacts negatively on the immune system [4]. This is due to the sustained hyperglycemia that impairs the general immune system in people with diabetes through various pathways that lead to an immune-compromised state [5]. The exponential increase in diabetes mellitus populations significantly contributes to increased hospitalizations [6] [7]. Despite the recent advances in medicine to keep the glucose levels of people with diabetes under control; it is still a major concern that infections continue to cause substantial morbidity and mortality in type 2 diabetes mellitus [7]. Bacteria are among the common etiological agents. Studies have reported a high prevalence of E. coli, and Klebsiella spp among urinary tract infections in type 2 diabetic patients [8] [9]. Although there have been substantial studies carried out around the world concerning type 2 diabetics, studies that have utilized advanced methods in Africa are few and these have mostly been conducted outside Sub-Saharan Africa such as in Egypt [10]. The studies done in Sub-Saharan Africa hsave shown a range of 20% to 39% percent prevalence of urogenital infections in diabetes and the incidence is more than double compared to people without diabetes [11]-[14]. These studies have led to various improved interventions in the fight to prevent and control infections in people with diabetes. However, it is evident that as the cases of diabetes increase, the infection rate that is associated with drug-resistant pathogens also increases [5] [15]. Resistance to a range of antibiotics which include beta-lactams and non-beta-lactams has been reported [5] [11]. Resistance to antimicrobials would eventually diabetic populations susceptible to an increased risk of persistent and recurrent infections resulting in higher medical costs, poor quality of life as well as increased mortality and morbidity.
Urinary tract infections are more frequent in people living with diabetes mellitus than in those without diabetes [15]. Presently, there is evidence that the prevalence of type 2 diabetes mellitus is substantially growing each year [2] [16] and most of the reported infections associated with these populations are developing multidrug resistance [9]. Bacterial uropathogens are significant contributors to disease and disability in type 2 diabetes mellitus patients [17].
In Sub-Saharan Africa, some studies have reported varying prevalences of uropathogens in people with type 2 diabetes with increased resistance to commonly used antibiotics being reported [11] [14]. However, studies on the same are short in Malawi. The increased prevalence of uropathogens as well as their increased resistance to medication has overall translated into over-prescription of drugs, resulting in ineffective treatment and more drug resistance [10]. This consequently translates to a poor quality of life for people living with diabetes i.e. poor disease prognosis, increased length and frequency of hospitalization, and increased disease-related costs. Therefore, there was a need for more studies to be conducted to generate relevant information on the spectrum of etiologies of infections, and phenotypic and genomic characteristics of bacterial uropathogens associated with disease in people with type 2 diabetes in Sub-Saharan Africa and indeed in Malawi.
2. Materials and Methods
Study design, site, and population
This was a cross-sectional study conducted at Mzuzu Central Hospital a referral Hospital in Mzuzu City, Malawi’s northern region in South-East Africa. Demographic data on persons living with type 2 diabetes were collected and associations between the independent variables and dependent variables were determined. A total of 294 consenting participants above 18 with type 2 diabetes and without any other immunocompromising condition were recruited for this study.
Data and sample collection
A structured questionnaire was used to collect socio-demographic data such as gender, age, ethnicity, marital status, and occupation. It was also used to record information on Ethnicity and medical history such as duration of diabetes and medication. Each type 2 diabetic participant was instructed on how to collect a “clean-catch” mid-stream urine into sterile leak-proof containers.
Laboratory analysis
Urine samples from type 2 diabetic participants underwent a chain of laboratory tests to grow, isolate, and identify Gram-negative bacteria that cause Urinary Tract Infections. The tests included bacterial culture, gram staining, bacterial subculture, biochemical tests (Indole, TSI, Citrate, Urease), Kirby Bauer disc diffusion antimicrobial susceptibility test, and ESBL testing following the standard procedures as described by clinical laboratory standard Institute (CLSI) [18].
Urine culture for bacteria
The urine samples were cultured on a standard 60 × 15 mm cysteine lactose electrolyte deficient (CLED) agar (Oxoid, UK) plate prepared by the manufacturing company’s instructions, leaving a single streak across the center, and then spread the inoculum evenly distributed in a cross-zigzag pattern to the primary streak. The culture plates were incubated at 37˚C for 18 - 24 hours [18]. After which they were observed for growth. Bacterial growth of ≥105 CFU/ml (colony-forming unit per milliliter) was indicative of significant growth [18].
Identification of bacteria
Bacteria identification from pure culture plates was based on colonial morphology, staining and biochemical tests. A representative colony on each plate was picked, Gram-stained, and further tested using sugar fermentation TSI, Indole, Citrate, Oxidase, and Urease biochemical tests [18]. Furthermore, the identification of gram-negative species was performed by Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometry (Vitek, biomerieux).
Antibiotic Susceptibility Testing (AST)
Antibiogram was conducted by the Kirby-Bauer disc diffusion method from pure bacterial colonies emulsified in saline and then compared with 0.5 McFarland standard [18]. The suspension was inoculated on a dried surface of the Mueller-Hinton agar plate (Oxoid) and the following commercially available antibiotics were applied on inoculated Mueller-Hinton agar plates: ampicillin (30 μg), cefotaxime (30 μg), ceftriaxone (30 μg), ceftazidime (30 µg), ciprofloxacin (30 μg), gentamicin (30 μg) (Oxoid, UK). After, 18 - 24 hours of incubation at 37˚C, zones of growth of inhibition were measured using a caliper and interpreted as per the Clinical Laboratory Standard Institute guidelines (CLSI) [18].
Phenotypic confirmatory disc diffusion test (PCDDT)
All E. coli isolates with reduced susceptibility to 3rd generation cephalosporin (cefotaxime, ceftazidime, or ceftriaxone) were selected for a phenotypic Extended Spectrum Beta-Lactamase (ESBL) confirmatory test following the CLSI 2019 guidelines [18]. Mueller-Hinton agar was inoculated with test organisms and after inoculation, a combination of cefotaxime (30 μg), cefotaxime plus clavulanic acid (30 μg/10μg) and ceftadizime (30 μg), ceftadizime plus clavulanic acid (30 μg /10μg) (Oxoid, UK) were placed 20 mm apart from center disc. Inoculated plates were incubated aerobically at 37˚C for 18 - 24 hours. According to CLSI (2019) [18] criteria, the formation of ESBL was indicated by an inhibition zone of ≥5 mm between cefotaxime plus clavulanic acid and cefotaxime, or between ceftadizime and ceftadizime plus clavulanic acid and ceftadizime [18]. Klebsiella pneumoniae ATCC 700603, and E. coli ATCC 25922 were used as positive and negative controls respectively.
Statistical analysis and presentation
Data were analyzed using Stata SE 15.1. For socio-demographic categorical data (e.g. gender, age group, ethnicity), summary tables of counts and percentages were presented and for continuous variables, mean and standard deviations were presented after testing for normality. Bivariate analysis using Pearson’s Chi-square test was used to determine factors associated with Urinary Tract Infections. A P-value of less than 0.05 (p- < 0.05) denoted statistical significance.
3. Results
Demographics of participants
The study recruited 294 participants. The majority of participants were females (54%) compared to Males (46%). The mean age was 55 years (age range; of 19 - 93 years). The highest level of education was between primary and secondary for the majority of participants with 45% and 39% respectively with the least being tertiary education level (9%). With regards to the duration of type 2 diabetes since diagnosis, the majority of participants were those diagnosed with type 2 diabetes between 5 - 10 years (41%) followed by those diagnosed with type 2 diabetes for less than 5 years since diagnosis (37%), and the least representation from those with diabetes for more than 10 years (22%). Most participants were in the category of having a mean random blood sugar (RBS) level of >190 g/dl (63%) than those with a mean RBS ≤ 190 g/dl (37%). In terms of occupation, most participants were unemployed (70%), followed by those employed (14%), with traders representing 10% of the participants and Artisans, and Students representing 6% of participants. Furthermore, in terms of marital status most participants were married (69.4%) followed by widows/widowers (22.4%), and the least were those who were single/divorced/separated (8.2%). In terms of ethnicity, most participants were Tumbukas (68%) compared to Chewas and other ethnic groups (Tonga/Ngonde/ Yao) with 18% and 14% respectively as shown in Table 1.
Prevalence of Urinary Tract Infections in type 2 diabetes
An overall Urinary Tract Infection prevalence of 11% (n = 294) was established. Prevalence was higher in female participants (13.2%) than in male participants (8.1%). With regards to the period of type 2 diabetes since diagnosis; those with 5 - 10 years had the highest prevalence of Urinary Tract Infections (16.7%) followed by those with less than 5 years since diagnosis (7%) and the least Urinary Tract Infection prevalence was observed in those who had been diagnosed over 10 years with 6.2%. The prevalence was higher in those with a mean random blood sugar (RBS) level of >190 g/dl (13.1%) than those with a mean RBS ≤ 190 g/dl. The prevalence of Urinary Tract Infections was also higher in traders (28.6%) compared to the employed (16.6%), unemployed (7.2%), Artisans, and Students (11%). Equally, there was a higher prevalence of Urinary Tract Infections (12.1%) in those aged over 65 years, followed by those between 36 - 50 years of age with a
Table 1. Demographics.
Socio-demographic Characteristics |
Number of
participants (%) |
n = 294 |
Gender |
|
|
Male |
135 (46) |
|
Female |
159 (54) |
|
mean RBS |
|
|
≤190 g/dl |
109 (37) |
|
>190 g/dl |
185 (63) |
|
Period with Diabetes |
|
|
<5 years |
109 (37) |
|
5 - 10 years |
120 (41) |
|
>10 years |
65 (22) |
|
Occupation |
|
|
Unemployed |
206 (70) |
|
Employed |
42 (14) |
|
Trader |
28 (10) |
|
Other (Artisan/Student) |
18 (6) |
|
Age Groups (years) |
|
|
19 - 35 |
30 (10) |
|
36 - 50 |
85 (29) |
|
51 - 65 |
113 (38.5) |
|
>65 |
66 (22.5) |
|
Marital Status |
|
|
Married |
204 (69.4) |
|
Widow/Widower |
66 (22.4) |
|
Single/Divorced/Separated |
24 (8.2) |
|
Level of education |
|
|
No formal/Primary |
153 (52) |
|
Secondary |
116 (39) |
|
Tertiary |
25 (9) |
|
Ethnicity |
|
|
Tumbuka |
200 (68) |
|
Chewa |
53 (18) |
|
Other (Tonga/Ngonde/Yao) |
42 (14) |
|
Urinary Tract Infections prevalence of 11.8% and the least prevalence Urinary Tract Infections of 9.7% in the 51 - 65 year age group. In terms of marital status, the highest prevalence was observed in widows/widowers (12.1%) followed by the married (11.8%), and least in those who were single/divorced/separated (4.2%). Those with no formal/only attained primary education (11.8%) had the highest prevalence compared to those who had attained secondary (10%) and tertiary (8%) education. In terms of ethnicity, the prevalence of Urinary Tract Infections, was also higher in Tumbukas (12.5%) compared to Chewas (3.8%) and other Ethnic groups (Tonga/Ngonde/Yao) 11.9%, as shown in Table 2.
Table 2. Prevalence of urinary tract infections in various demographics.
Demographic characteristics |
Number of participants |
UTI prevalence% |
With UTIs |
Without UTIs |
Overall |
32 |
262 |
11 |
Gender |
|
|
|
Male |
11 |
124 |
8.1 |
Female |
21 |
138 |
13.2 |
Average RBS |
|
|
|
≤190 g/dl |
4 |
105 |
3.7 |
>190 g/dl |
28 |
157 |
15.1 |
Period with Diabetes |
|
|
|
<5 years |
8 |
101 |
7.3 |
5 - 10 years |
20 |
100 |
16.7 |
>10 years |
4 |
61 |
6.2 |
Occupation |
|
|
|
Unemployed |
15 |
191 |
7.3 |
Employed |
7 |
35 |
16.7 |
Trader |
8 |
20 |
28.6 |
Other (Artisan/Student) |
2 |
16 |
11.1 |
Age Groups (years) |
|
|
|
19 - 35 |
3 |
27 |
10.0 |
36 - 50 |
10 |
75 |
11.8 |
51 - 65 |
11 |
102 |
9.7 |
>65 |
8 |
58 |
12.1 |
Marital Status |
|
|
|
Married |
23 |
181 |
11.3 |
Widow/Widower |
8 |
58 |
12.1 |
Single/Divorced/Separated |
1 |
23 |
4.2 |
Level of education |
|
|
|
No formal/Primary |
18 |
135 |
11.8 |
Secondary |
12 |
104 |
10.3 |
Tertiary |
2 |
23 |
8.0 |
Ethnicity |
|
|
|
Tumbuka |
25 |
175 |
12.5 |
Chewa |
2 |
51 |
3.8 |
Other (Tonga/Ngonde/Yao) |
5 |
37 |
11.9 |
Distribution of positive culture results by demographic characteristics
The majority of isolates were recovered from female participants compared to males with 65.6%, (n = 32) and 34.4% (n = 32) in female and male patients respectively. Participants aged between 51 and 65 years had the highest prevalence (34.3%) of Urinary Tract Infections and the least prevalence was in the 19-35-year-age group with 9.4% of the isolates recovered. Most isolates (56.3%) were recovered from those who had no formal education or had only attained primary education with the least recovered from those with tertiary education (6.3%). In terms of marital status, 72% of the isolates were recovered from Married participants with the least isolated from those single/separated/divorced at 3%. Most Isolates were recovered from the Tumbuka subjects and the least from the Tonga/Ngonde/Yao with regards to Ethnicity with 78% and 16% from the Tumbukas and Tonga/Ngonde/Yao respectively.
Distribution of Bacteria isolates in Type 2 diabetic participants
A total of 32 (11%) bacterial uropathogens were isolated from positive urine culture (≥105 CFU/ml) on which identification was conducted. E. coli was the most recovered isolate with 43.8% followed by Klebsiella spp. (34.4%), Enterobacter spp. (12.5%), Serratia spp (6.2%) and 3.1% Morganella spp., as shown in Figure 1.
Antibiotic resistance pattern of isolates
The highest level of antibiotic resistance to one of any of the antibiotics utilized was observed in 57% (n = 14) of E. coli isolates, followed by Enterobacter spp., 25% (n = 4) resistance and Klebsiella spp with 18% (n = 11) resistant to antibiotics. Among all the isolates, Morganella spp and Serratia spp showed no resistance to any of the antibiotics utilized in the study. However, multi-drug (antibiotic) resistance (MDR) was observed in all the resistant E. coli isolates. The majority of the E. coli isolates were resistant to Ampicillin with only 14% of isolates being sensitive. However, the E. coli isolates were highly susceptible to Gentamicin with 100% sensitivity, followed by Ciprofloxacin with 86% sensitivity. Furthermore, at least half of the E. coli isolates were resistant to one or more of the 3rd generation cephalosporin antibiotics such as Ceftazidime and cefotaxime (with 43% and 50% sensitivity for the antibiotics respectively), as shown in Table 3.
![]()
Figure 1. Percentage distribution of Bacteria isolates in type 2 diabetic subjects with a mean random Blood sugar (RBS) level of RBS ≤ 190 g/dl and >190 g/dl.
Table 3. Overall antibiotic susceptibility pattern of E coli isolates.
Antibiotic name |
Number of samples (%) |
n = 14 |
Resistant |
Susceptible |
Gentamicin (CN) |
0 (0) |
14 (100) |
|
Ampicillin (AMP) |
12(86) |
2 (14) |
|
Ciprofloxacin (CIP) |
2 (14) |
12 (86) |
|
Cefotaxime (CTX) |
7(50) |
7 (50) |
|
Ceftazidime (CAZ) |
8 (57) |
6(43) |
|
Ceftriaxone (CRO) |
3 (21) |
11 (79) |
|
Phenotypic beta-lactamase production in E. coli isolates
The Combined disc diffusion test showed that 63% (n = 8) of the E. coli isolates which were resistant to 3rd generation cephalosporins were positive for ESBL production. Thus, regarded as having the genes that code for enzymes (beta-lactamase) thus, having capability of producing one or more of the extended spectrum beta-lactamases (ESBL) that cause beta lactam antibiotic resistance including resistance to 3rd generation cephalosporins.
Association between UTIs and independent variables
In this study an overall UTIs prevalence of 11% (n = 294) was established. The prevalence was significantly higher in those with a mean random blood sugar (RBS) level of >190 g/dl (13.1%) than those with a mean RBS ≤ 190 g/dl (X2, p value = 0.029). The prevalence of UTIs was also significantly higher in traders (29%, p value = 0.019) compared to the employed (16.6%), unemployed (7.2%), Artisans, and Students (11%). Equally, there was a significant prevalence of UTIs in those who had lived with diabetes between 5 and 10 years (17%, X2, p value = 0.029) since diagnosis compared to those who had lived with Type 2 diabetes for less than 5 years.
Prevalence of UTIs was higher in female participants compared to males with 65.6% and 34.4% in female and male patients respectively. In terms of age groups; participants aged between 51 - 65 years had the highest prevalence of UTIs (34.3%) and the least prevalence was in the 19 - 35 years age group with 9.4% of the isolates recovered. Furthermore, most isolates (56.3%) were recovered from those who had no formal education or had only attained primary education with the least recovered from those with tertiary education (6.3%). Concerning marital status, 72% of the isolates were recovered from Married participants with the least isolated from those single/Separated/divorced at 3%. A majority of Isolates were recovered from the Tumbuka subjects and the least from the Tonga/Ngonde/Yao when it came to Ethnicity with 78% and 16% from the Tumbukas and Tonga/Ngonde/Yao respectively. However, age, gender, Level of education, ethnicity, and marital status were not significant contributors to the UTI prevalence.
Furthermore, at least half of the E. coli isolates were resistant to one or more 3rd generation cephalosporin antibiotics such as Ceftazidime and cefotaxime (with 43% and 50% sensitivity for the antibiotics respectively). However, these differences in resistance patterns between isolates from the various demographics and other categories assigned in this study were not statistically significant, as shown in Table 4.
Table 4. Association between UTI and age, gender, Glucose levels, duration of diabetes, level of education, ethnicity and marital status.
Socio-demographic Characteristics |
Number of participants (%) |
n = 294 |
With UTIs |
Without UTIs |
Total |
X2:
p-Value |
Gender |
|
|
|
|
Male |
11 |
124 |
135 (46) |
0.159 |
Female |
21 |
138 |
159 (54) |
0.159 |
Average RBS |
|
|
|
|
≤190 g/dl |
4 |
105 |
109 (37) |
>0.05 |
>190 g/dl |
28 |
157 |
185 (63) |
0.002 |
Period with Diabetes |
|
|
|
|
<5 years |
8 |
101 |
109 (37) |
>0.05 |
5 - 10 years |
20 |
100 |
120 (41) |
0.029 |
>10 years |
4 |
61 |
65 (22) |
>0.05 |
Occupation |
|
|
|
|
Unemployed |
15 |
191 |
206 (70) |
>0.05 |
Employed |
7 |
35 |
42 (14) |
>0.05 |
Trader |
8 |
20 |
28 (10) |
0.019 |
Other (Artisan/Student) |
2 |
16 |
18 (6) |
>0.05 |
Age Groups (years) |
|
|
|
|
19 - 35 |
3 |
27 |
30 (10) |
>0.05 |
36 - 50 |
10 |
75 |
85 (29) |
>0.05 |
51 - 65 |
11 |
102 |
113 (38.5) |
>0.05 |
>65 |
8 |
58 |
66 (22.5) |
>0.05 |
Marital Status |
|
|
|
|
Married |
23 |
181 |
204 (69.4) |
>0.05 |
Widow/Widower |
8 |
58 |
66 (22.4) |
>0.05 |
Single/Divorced/Separated |
1 |
23 |
24 (8.2) |
>0.05 |
Level of education |
|
|
|
|
No formal/Primary |
18 |
135 |
153 (52) |
>0.05 |
Secondary |
12 |
104 |
116 (39) |
>0.05 |
Tertiary |
2 |
23 |
25 (9) |
>0.05 |
Ethnicity |
|
|
|
|
Tumbuka |
25 |
175 |
200 (68) |
>0.05 |
Chewa |
2 |
51 |
53 (18) |
>0.05 |
Other (Tonga/Ngonde/Yao) |
5 |
37 |
42(14) |
>0.05 |
4. Discussion
Prevalence of Urinary Tract Infections by demographic characteristics
The majority of isolates were recovered from female participants compared to males with 65.6% (n = 32) and 34.4% (n = 32) in female and male patients respectively. A study conducted by Gutema found gender to be a significant risk factor in the prevalence of urinary tract infections of bacterial etiology [19]. However, in this study, gender had no significant association with the prevalence of urinary tract infections in type 2 diabetes. This finding is supported by other research that found gender not to be a significant risk factor for the occurrence of urinary tract infections [5] [15] [20] [21]. This could be explained by previous research showing that women seek medical attention more often than males, thus, leading to higher recruitment of women for health-related studies [22]-[24]. This was also the case in this study with the majority of participants being female.
The prevalence of UTIs was significantly higher in those with a mean random blood sugar (RBS) level of >190 g/dl (13.1%) than in those with a mean RBS ≤ 190 g/dl. The prevalence of Urinary Tract Infections was also significantly higher in traders (29%, p value = 0.019) compared to the employed (16.6%), unemployed (7.2%), Artisans, and Students (11%). Equally, there was a significant prevalence of Urinary Tract Infections in those who had lived with diabetes between 5 and 10 years (17%, P value = 0.029) since diagnosis compared to those who had lived with type 2 diabetes for less than 5 years. This finding is comparable with other findings of a systematic review and meta-analysis conducted in Addis Ababa, Ethiopia [25]. This association is explained by the ability of microorganisms to thrive better in a hyperglycemic environment [26]. Furthermore, Diabetes’ effects on the immune system include impaired immune responses within the hyperglycemic state of an individual [26]; lower production of interleukins in response to infections; reduced chemotaxis and phagocytic activity, immobilization of poly-morphonuclear leukocytes; glycosuria and gastrointestinal and urinary dysmotility [27]. Uncontrolled blood glucose levels result in shedding glucose in the urine, providing a conducive environment for bacteria growth in the urinary tract [9] [28].
Older (≥50 years) participants had a higher prevalence of Urinary Tract Infections with females aged 50 - 54 years having the highest prevalence of Urinary Tract Infections (35%) with the least prevalence being in the younger age groups under 35 years. These findings agree with those from Iran and Ethiopia that reported an increased prevalence of Urinary Tract Infections in older age groups among type 2 diabetic patients that is associated with poor control of diabetes as age advances [19] [28]. This was also the case in this study, as younger age groups and those with the least duration of diabetes had more controlled levels of blood glucose and lower prevalence of UTIs. However, there was no significant association between age, duration of diabetes, and UTIs prevalence, this is in line with other studies conducted in Ghana and Iran [11] [28]. Concerning education, most isolates (56.3%) were recovered from those who had no formal education or had only attained primary education with the least recovered from those with tertiary education. In terms of marital status, 72% of the isolates were recovered from Married participants with the least isolated from those single/Separated/divorced at 3%. A majority of Isolates were recovered from the Tumbuka subjects and the least from the Tonga/Ngonde/Yao when it came to Ethnicity with 78% and 16% from the Tumbukas and Tonga/Ngonde/Yao respectively. However, age, gender, Level of education, ethnicity, and marital status were not significant contributors to the UTI prevalence.
Antibiotic susceptibility pattern of E. coli and treatment considerations
The findings from this study showed a high prevelance of urinary tract infections coupled with high resistance rates to antibiotics commonly used for treatment, which is also similar to other studies conducted in sub-Saharan Africa [11]. Despite the prevalence and resistance trend being high in type 2 diabetes, the recommended first-line treatment and duration of antibiotics for urinary tract infections is similar to that of other patients [15]. Some studies, based on the findings that prevalence and antibiotic resistance is substantially higher in type 2 diabetics, have argued that patients with type 2 diabetes should receive a variation of antibiotics and longer antibiotic treatment than patients without diabetes mellitus for effective and successful therapy [29]. The choice of antibiotics in patients with type 2 diabetes also needs to consider possible drug interactions that could cause impaired glucose homeostasis [30]-[32]. Furthermore, dosage adjustment is also required for some antimicrobial agents in type 2 diabetes patients with renal impairment [33]. This study found gentamicin (84.2% susceptibility) and fluoroquinolones (84.2% to 86.8% susceptibility) effective against E. coli. Thus, these antibiotics could be utilized in treating UTIs of E. coli etiology. These findings align with findings from other studies carried out in southern Nigeria and Ethiopia with E. coli sensitivity ranging from 80% to 93% to fluoroquinolones and gentamicin [11] [34] [35]. On the other hand, a study conducted by Naqid observed an extreme susceptibility of uropathogenic E. coli to ciprofloxacin in Iraq [36], while high susceptibility of E. coli to gentamicin and cefotaxime were shown in a study conducted in Tunisia [37]. The highest level of antibiotic resistance to one of any of the antibiotics utilized was observed in E. coli isolates (57%; n = 14), followed by Enterobacter (25%; n = 4) resistance and Klebsiella spp. (18%; n = 11) resistant to antibiotics. Among all the isolates, Morganella spp and Serratia spp showed no resistance to any of the antibiotics utilized in the study. E. coli isolates were highly susceptible to gentamicin with 100% sensitivity, followed by ciprofloxacin with 86% sensitivity. However, multi-drug (antibiotic) resistance (MDR) was observed in all the resistant E. coli isolates. Most of the E. coli isolates were resistant to ampicillin, with only 14% being sensitive. Some E. coli isolates were resistant to one or more of the 3rd generation cephalosporin antibiotics such as ceftazidime and cefotaxime (with 43% and 50% sensitivity for the antibiotics respectively). The resistance could be attributed to overuse, abuse, poor compliance to treatment, and use of suboptimal drugs [38] [39] [40]. One of the major resistance mechanisms is by the production of ESBL enzymes that hydrolyze the antibiotics [41]. However, these differences in resistance patterns between isolates from the various demographic and other categories assigned in this study were not statistically significant.
ESBL-producing E. coli and multi-antibiotic resistance
The confirmatory disc diffusion test showed that E. coli isolates that were resistant to 3rd generation cephalosporins tested positive for ESBL production, thus regarded as having the genes that code for enzymes (beta-lactamases), therefore, having the capability of producing one or more of the extended-spectrum beta-lactamases that cause beta-lactam antibiotic resistance including resistance to 3rd generation cephalosporins. Similar findings were reported by Ugwu in southern Nigeria, where a tertiary care facility’s outpatient urine samples contained a significant concentration of E. coli strains that produced an extended-spectrum band [35]. The high level (86%) found in this study is comparable with reports of 30% - 90% of ESBL-producing E. coli from various countries [42]-[45]. Additionally, high levels of resistance by E. coli were reported in systematic reviews by Carrillo-Larco in 2021 and Salari in 2022 [25] [46]. These reports particularly highlighted that resistance was linked to the production and utilization of ESBL enzymes [25] [46]. These ESBL genes can be spread horizontally (carried on plasmids), making it easier for bacteria of different species to transmit resistance genes [47]. Because of this, empirical UTI therapy is difficult and has erratic results [48]. The results of other investigations in Ghana and Bangladesh, which showed higher multi-antibiotic resistance of up to 93% to routinely used antibiotics, are comparable to this study [11] [49]. Antibiotic usage and abuse, as well as the administration of less-than-ideal medications, have all been linked to the development of resistance [39] [40]. This might lead to greater treatment expenses, a bigger chance of complications, and a higher rate of morbidity and mortality.
The high rates of resistance by ESBL-producing E. coli (86% of isolates) are a serious concern [25]. Numerous studies from Sub-Saharan Africa have reported a high prevalence of ESBL-producing E. coli [42]-[44]. These observations tie in with the ones found in this study (86% ESBL E. coli), this entails a potential increase in ESBL and general MDR resistance with the increasing population of people with type 2 diabetes in Malawi. Therefore, it is critical to insist on antibiotic susceptibility testing before prescription. Curbing this serious threat to public health would need strategies to block the spread of resistant uropathogenic bacteria in both the lower-risk and higher categories of these type 2 diabetic individuals who have demonstrated a high prevalence of UTIs.
5. Conclusion and Recommendations
According to this study, type 2 diabetic patients had a significant prevalence of UTIs of bacterial etiology, particularly those with higher mean Random Blood Sugar levels (>190 g/dl). The phenotypic analysis found a concerning 62.5% ESBL-producing E. coli. Additionally, the ESBL-producing E. coli had high resistance levels to several antibiotics. This presents a serious public health threat that calls for well-informed solutions. Therefore, it is recommended that antibiotics be judiciously used by utilizing antimicrobial susceptibility testing before prescription, encouraging standard prescribing practices, and sufficient patient education on the use of antibiotics and the growing trend of antibiotic resistance. The findings of this study have demonstrated the significance of combining phenotypic methods with routine testing for antibiotic sensitivity to gain a deeper understanding of the basic components of antibiotic resistance in settings with limited resources. Thus, tests for common ESBL-producing strains are required.
6. Study Limitations
Due to resource constraints, ESBL tests were only done on E. coli isolates. Therefore, subsequent studies may focus on ESBL characterization of all uropathogens to establish a broader range of knowledge on bacteria that are resistant to antibiotics by coding for these enzymes.
Ethics Statement
The study project was authorized by MZUNIREC and issued a clearance certificate (Ref No. MZUNIREC/DOR/23/34). Additionally, official approval was requested from Mzuzu Central Hospital. The participants were asked for their informed consent by declaring it in writing.
Funding
The study received funding from the African Population Health Research Center.
Acknowledgments
We express our gratitude to everyone who helped to make this work possible.
Author Contribution
Thomas Stuart Mughogho developed the concept and conducted analysis and interpretation of study findings. All co-authors contributed to the review and write-up of the manuscript.